contraindications: Absolutely contraindicated in individuals with prostate or breast carcinoma.
Not for use by women — virilisation risk is severe and partially irreversible.
Contraindicated in those with severe hepatic or renal impairment.
Do not use if hypersensitivity to trenbolone or any oil-based excipient in the formulation is known or suspected.
Persons under 21 years of age should not use any trenbolone-based compound — endocrine system maturation is incomplete.
side_effects: Androgenic: accelerated scalp hair thinning in genetically predisposed individuals, acne, increased body hair.
Cardiovascular: measurable reduction in HDL cholesterol; elevated haematocrit is possible with extended use.
Progestogenic activity: potential for elevated prolactin in susceptible individuals — monitor and manage with a dopamine agonist if needed.
Night sweating and elevated resting body temperature are frequently reported, particularly in the first weeks.
Endogenous testosterone production is suppressed; exogenous testosterone supplementation is therefore mandatory throughout the cycle.
monitoring: Full blood panel — including LH, FSH, total testosterone, haematocrit, lipid profile, and liver enzymes — at baseline and at the mid-cycle point.
Blood pressure should be self-monitored weekly; trenbolone can increase cardiovascular strain.
Prolactin levels should be checked at mid-cycle, especially if nipple sensitivity or unusual mood changes appear.
Renal markers (creatinine, BUN) are worth including in the baseline panel given trenbolone's reputation for increasing them in susceptible individuals.
pct: PCT should commence 2–3 days after the final trenbolone acetate injection, taking advantage of the short ester's rapid clearance.
A standard SERM-based PCT (clomiphene citrate or tamoxifen) for 4 weeks is the minimum recommended recovery framework.
If prolactin was elevated during the cycle, cabergoline should be discontinued gradually rather than abruptly before starting the SERM phase.
Bloodwork 4–6 weeks post-PCT is essential to confirm full HPTA recovery before planning any subsequent cycle.